A stochastic differential equation model for the spread of HIV amongst people who inject drugs [PDF]
In this paper, we introduce stochasticity into the deterministic differential equation model for the spread of HIV amongst people who inject drugs (PWIDs) studied by Greenhalgh and Hay [10]. This was based on the original model constructed by Kaplan [17]
Greenhalgh, David +2 more
core +8 more sources
Not in the vein: 'missed hits', subcutaneous and intramuscular injections and associated harms among people who inject psychoactive drugs in Bristol, United Kingdom [PDF]
Background: The extent of intentional or accidental subcutaneous and intramuscular injections and the factors associated with these have rarely been studied among people who inject drugs, yet these may play an important role in the acquisition bacterial ...
Advisory Council on the Misuse of Drugs +47 more
core +1 more source
Managing physical health problems in people who inject drugs [PDF]
GPs have an important role in addressing the physical health complications of illicit drug use and in particular in people who inject drugs (PWID). Managing these morbidities is within the remit of every GP and does not require any special interest or knowledge.1 A balance will need to be struck between trying to accomplish too much in a single visit ...
O'Donnell, Patrick, Lawson, Euan Malcolm
openaire +2 more sources
A pragmatic harm reduction approach to manage a large outbreak of wound botulism in people who inject drugs, Scotland 2015 [PDF]
Background People who inject drugs (PWID) are at an increased risk of wound botulism, a potentially fatal acute paralytic illness. During the first 6 months of 2015, a large outbreak of wound botulism was confirmed among PWID in Scotland, which resulted ...
Amanda Weir +43 more
core +1 more source
Examining non-AIDS mortality among people who inject drugs [PDF]
To systematically review and analyse data from cohorts of people who inject drugs (PWID) to improve existing estimates of non-AIDS mortality used to calculate mortality among PWID in the Spectrum Estimates and Projection Package.Systematic review and meta-analysis.We conducted an update of an earlier systematic review of mortality among PWID, searching
Mathers, BM, Degenhardt, L
openaire +3 more sources
Hepatitis C Virus Vaccines Among People Who Inject Drugs [PDF]
Most people who inject drugs (PWID) are infected with hepatitis C virus (HCV), and PWID have the highest risk of HCV infection of any risk group. The incidence of HCV infection is 5%-25% per year, demonstrating continued need for HCV infection prevention in PWID.
Andrea L, Cox, David L, Thomas
openaire +2 more sources
Association between harm reduction intervention uptake and skin and soft tissue infections among people who inject drugs [PDF]
Background: Bacterial skin and soft tissue infections (SSTIs) are a health issue for people who inject drugs (PWID). There is a lack of evidence on the associations between harm reduction (HR) uptake and SSTIs.
Dunleavy, Karen +7 more
core +5 more sources
Concurrent drug injection during opioid agonist treatment among people who inject drugs in Ukraine [PDF]
Ongoing drug use during opioid agonist treatment (OAT) negatively affects treatment and health outcomes, and increases treatment dropout. This study aimed to examine correlates of concurrent illicit drug use among OAT patients in Ukraine. A random sample of 434 patients currently on OAT receiving buprenorphine (BMT) or methadone maintenance treatment ...
Iuliia Makarenko +7 more
openaire +2 more sources
By dawn or dusk—how circadian timing rewrites bacterial infection outcomes
The circadian clock shapes immune function, yet its influence on infection outcomes is only beginning to be understood. This review highlights how circadian timing alters host responses to the bacterial pathogens Salmonella enterica, Listeria monocytogenes, and Streptococcus pneumoniae revealing that the effectiveness of immune defense depends not only
Devons Mo +2 more
wiley +1 more source
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg +43 more
wiley +1 more source

